Deals and M&As this week: Syncona, Medrobotics, Micrima

22 June 2018 (Last Updated July 27th, 2018 07:37)

Syncona Ltd has completed the acquisition of a surgical platform for sub-retinal delivery from Janssen Biotech Inc.

Syncona Ltd has completed the acquisition of a surgical platform for sub-retinal delivery from Janssen Biotech Inc.

Based in the UK, Syncona is a life sciences and healthcare company, while Janssen Biotech is a US-based biotechnology company that develops diagnostic assays.

Medrobotics Corp has announced a $25m venture debt investment from US-based venture capital firm Western Technology Investment (WTI).

Based in the US, Medrobotics is a manufacturer of the Flex Robotic System, a surgical platform with a steerable scope.

The company plans to use the funds towards the development of its products and applications and to expand its manufacturing capabilities to meet the rising demand for its products.

Micrima has raised £4.4m in an equity financing round led by Technology Venture Partners, The Angel CoFund (ACF), and Venture Founders.

The funding round also included the participation of a group of returning and new individual investors, while it increased Micrima’s total proceeds to £10.7m.

Based in the UK, Micrima is a developer of a breast cancer screening system.

“Philips will strengthen its position in the €1.4bn ($1.6bn) resuscitation and emergency care market and develop its digital transformation capabilities.”

All the investors participated in the funding round are also based in the UK.

Micrima plans to use the funds towards the development of its CE-Marked radio wave breast imaging system MARIA and expand its team size.

Zeus Industrial Products Inc has completed the acquisition of MWC Technologies LLC for an undisclosed sum.

Based in the US, Zeus manufactures precision polymer extrusions, while MWC, also based in the US, is a developer of medical components.

Zeus will commercialise and expand MWC’s product portfolio.

Philips has completed the acquisition of Remote Diagnostic Technologies (RDT) for an undisclosed sum.

Philips will strengthen its position in the €1.4bn ($1.6bn) resuscitation and emergency care market and develop its digital transformation capabilities.

Based in the Netherlands, Philips is a healthcare company and a supplier of therapeutic solutions for hospitals and medical care services, while RDT is a UK-based company specialising in the development of remote monitoring and resuscitation solutions for critical care services.